Sight Sciences wins $55.4 million patent judgment against Alcon in Hydrus Microstent case

• Sight Sciences received notice April 22, 2026 that U.S. District Court for District of Delaware entered final judgment in its patent case against Alcon over Hydrus Microstent.
• Final judgment upheld jury findings that asserted patent claims were valid and willfully infringed.
• Court awarded USD 55.4 million in total monetary damages.
• Judgment also set ongoing royalty at 10% of Hydrus revenue through patent expiration.
• Collection of damages remains subject to appeal, with payment not expected unless Alcon exhausts appeals or appeal window lapses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sight Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-171887), on April 23, 2026, and is solely responsible for the information contained therein.